Summary Hemostasis, LLC (Hemostasis) is a medical device manufacturer that provides bleeding control technology products. The company's products include hemostat patch, topical hemostat powder, hemostat dressing and intranasal splint, hemostatic patch, intranasal splint, topical hemostat sponge, and OTC powder and foam. Its hemostat dressing and intranasal splint is a foam splint made from natural chitosan based polymers; topical hemostat sponge is a plant-based polymer sponge; and hemostatic patch accelerates the clotting process to control bleeding. Hemostasis' OTC powder and foam provides quick and painless solution for minor to moderate bleeding wounds. The company's technologies include chitosan, biopolymers, and research and development. Hemostasis is headquartered in Saint Paul, Minnesota, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Hemostasis, LLC - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Hemostasis, LLC Company Snapshot 5 Hemostasis, LLC Company Overview 5 Hemostasis, LLC Pipeline Products and Clinical Trials Overview 6 Hemostasis, LLC - Pipeline Analysis Overview 8 Key Facts 8 Hemostasis, LLC - Major Products and Services 9 Hemostasis, LLC Pipeline Products by Development Stage 10 Hemostasis, LLC Pipeline Products Overview 11 Advanced Tissue Sealant 11 Advanced Tissue Sealant Product Overview 11 Bioabsorbable Bone Sealant 12 Bioabsorbable Bone Sealant Product Overview 12 ENT Hemostat 13 ENT Hemostat Product Overview 13 Hemostatic Gel 14 Hemostatic Gel Product Overview 14 Sealant Applicator 15 Sealant Applicator Product Overview 15 Hemostasis, LLC - Key Competitors 16 Hemostasis, LLC - Locations And Subsidiaries 17 Head Office 17 Appendix 18 Methodology 18 About GlobalData 18 Contact Us 18 Disclaimer 18
List of Tables
Hemostasis, LLC Pipeline Products and Clinical Trials Overview 6 Hemostasis, LLC Pipeline Products by Equipment Type 6 Hemostasis, LLC Pipeline Products by Indication 7 Hemostasis, LLC, Key Facts 8 Hemostasis, LLC, Major Products and Services 9 Hemostasis, LLC Number of Pipeline Products by Development Stage 10 Hemostasis, LLC Pipeline Products Summary by Development Stage 10 Advanced Tissue Sealant - Product Status 11 Advanced Tissue Sealant - Product Description 11 Bioabsorbable Bone Sealant - Product Status 12 Bioabsorbable Bone Sealant - Product Description 12 ENT Hemostat - Product Status 13 ENT Hemostat - Product Description 13 Hemostatic Gel - Product Status 14 Hemostatic Gel - Product Description 14 Sealant Applicator - Product Status 15 Sealant Applicator - Product Description 15
List of Figures
Hemostasis, LLC Pipeline Products by Equipment Type 7 Hemostasis, LLC Pipeline Products by Development Stage 10
Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected toRead More...
Global 3D scanning market is expected to be valued at USD 4,900.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing need for speedy and precise results with high efficiency is anticipated to drive the industry. 3DRead More...
Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from mainRead More...
U.S hairbrush market is estimated to exceed USD 1.2 billion by 2022, as per a new research report by Radiant Insights, Inc. Rising population along with ascending disposable income is expected to drive industry demand. Significant rise in disposableRead More...
Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to drivRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.